Underlying Causes and Treatment Modalities for Neurological Deficits in COVID-19 and Long-COVIDArticle Published on 2022-10-192023-07-10 Journal: ACS chemical neuroscience [Category] COVID19(2023년), [키워드] COVID-19 long-COVID neuro-COVID neurological deficits Post-COVID-19 sequelae Treatment Long-COVID. [DOI] 10.1021/acschemneuro.2c00482 PMC 바로가기
The Karolinska NeuroCOVID study protocol: Neurocognitive impairment, biomarkers and advanced imaging in critical care survivorsKarolinska NeuroCOVID 연구 프로토콜: 중환자 생존자의 신경인지 장애, 바이오마커 및 고급 영상Article Published on 2022-07-012022-09-11 Journal: Acta Anaesthesiologica Scandinavica [Category] MERS, 바이오마커, 진단, [키워드] Activation assessment Biomarker Biomarkers Brain brain injury brain MRI Care cause causes cellular cerebrospinal cerebrospinal fluid change Coagulopathy cognitive consequence COVID-19 COVID-19 pandemic Critical Critical care degeneration discharge disease exhibiting expressed fatigue finding Follow-up functional Health health-care system ICU identify immune impairment individual Inflammation Intervention magnetic resonance imaging marker Mental molecular MRI myriad neurocognitive neurocognitive disorders neurodegenerative neurological Neurological deficit neurological deficits neuronal outcome pathological mechanism Patient patient outcome assessment. patients treated performed plan plasma rehabilitation serum severe COVID-19 survivor Survivors Symptom target targets two patients [DOI] 10.1111/aas.14062 PMC 바로가기 [Article Type] Article
Olfactory dysfunction in COVID-19: pathology and long-term implications for brain healthReview article Published on 2022-06-202022-10-05 Journal: Trends in molecular medicine [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] acute phase Anosmia Brain cognitive COVID-19 COVID-19 cases Decreased downregulation dysfunction Evidence Health implication Inflammation likelihood long-lasting Mortality MOST neurological deficits Neuropathology occur Olfaction olfactory olfactory dysfunction pathology pathophysiology Quality of life question receptor proteins SARS-CoV-2 Smell loss structures Taste the SARS-CoV-2 virus [DOI] 10.1016/j.molmed.2022.06.005 [Article Type] Review article
Neurological and cognitive sequelae of Covid-19: a four month follow-upCovid-19의 신경학적 및 인지적 후유증: 4개월 추적Article Published on 2021-12-012022-09-11 Journal: Journal of Neurology [Category] SARS, 치료기술, [키워드] acute COVID-19 affected age cognitive Cognitive impairment Cohort COVID-19 COVID-19 case COVID-19 cases COVID-19 patient COVID-19 patients depression score detectable Diagnosis disorder emotional examined Follow-up Health care Health care worker incidence Infection Mann-Whitney morbidities nervous system neurological Neurological deficit neurological deficits not significantly different past Patient Peripheral nervous system post-acute COVID-19 SARS-COV-2 infection selected significantly higher Stress Support Symptom the mean two patients [DOI] 10.1007/s00415-021-10579-6 PMC 바로가기 [Article Type] Article
Chronic long‐COVID syndrome: A protracted COVID‐19 illness with neurological dysfunctionsEditorial Commentary Published on 2021-10-092022-11-01 Journal: CNS Neuroscience & Therapeutics [Category] COVID-19, MERS, [키워드] affected Brain cellular changes chronic CNS COVID‐19 COVID‐19 dysfunction expected Factor immune response individuals Inflammation Long‐COVID mechanism neurodegenerative neurological Neurological deficit neurological deficits Neuron Pathogenesis Patient presenting remained SARS‐CoV‐2 SARS‐CoV‐2 syndrome the patient Viral load [DOI] 10.1111/cns.13737 PMC 바로가기 [Article Type] Editorial Commentary
Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient리툭시맙 치료 다발성 경화증 환자에서 COVID-19 백신 접종 후 급성 재발 및 불량한 면역Case Reports Published on 2021-10-032022-09-11 Journal: Human vaccines & immunotherapeutics [Category] MERS, SARS, 진단, 치료기술, [키워드] Adenovirus adenovirus-based adhere adverse event anti-CD20 anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody assessments Ataxia Autoimmune disease Autoimmune diseases Awareness cerebellar peduncle clinical trial clinician Corticosteroid corticosteroid therapy COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines decision Detection limit develop diagnosed dose Efficacy fatigue first dose FIVE Gam-COVID-Vac Immunity immunization lesions magnetic resonance imaging Mild symptom mild symptoms monoclonal antibody multiple sclerosis myalgia Neurological deficit neurological deficits oral steroid Patient Phase I raise receive receiving right hemiplegia risk rituximab SARS-CoV-2 steroid subpopulations the patient the vaccine treated Treatment vaccination schedule Vaccine Vaccines weakness [DOI] 10.1080/21645515.2021.1928463 PMC 바로가기 [Article Type] Case Reports
[Cerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management][코로나19 예방접종 후 대뇌정맥동 혈전증 : 신경학적 및 방사선학적 관리]Review Published on 2021-10-012022-09-11 Journal: Radiologe [Category] SARS, 치료기술, [키워드] Adenovirus angiography antibodies antibody anticoagulation AstraZeneca cardinal symptom caused ChAdOx1 ChAdOx1 nCoV-19 choice clinical suspicion clot Combination complexes Computed tomography coronavirus disease Coronavirus disease 2019 cortical Course COVID-19 COVID-19 vaccination development Diagnosis diagnostic English headache heparin heparin-induced thrombocytopenia HIT2 immune immunomodulation Increased intracranial pressure individual intensity intracranial pressure Intravenous immunoglobulins Laboratory magnetic resonance imaging majority material medication MRI Neurological deficit neurological deficits oder Other Pathogenesis pathogenic plasma Platelet Platelet count platelet factor 4 radiological recipient recipients research findings SARS-CoV‑2 Screening Seizures Sinus thrombosis susceptibility Symptom Tage therapeutic thrombocytopenia thrombosis thrombotic Thrombotic thrombocytopenia Treatment vaccination Vaccination complications Vaccine vaccine-induced thrombotic thrombocytopenia Venen venous visual disturbance women worsening [DOI] 10.1007/s00117-021-00887-3 PMC 바로가기 [Article Type] Review
Combined intravenous immunoglobulin and baricitinib treatment for severe COVID-19 with rhabdomyolysis: A case report횡문근 융해증을 동반한 중증 COVID-19에 대한 정맥 면역글로불린 및 바리시티닙 병용 치료: 증례 보고Case Reports Published on 2021-09-012022-09-12 Journal: Journal of the Formosan Medical Association = Taiw [Category] SARS, 바이오마커, 진단, 치료법, [키워드] acute respiratory distress ARDS Asymptomatic carrier Baricitinib biochemical Biomarker Case report Clinical course Clinical improvement clinical recovery Combined combined use coronavirus disease correlated correlation COVID-19 creatine creatine kinase Cytokines disease severity Effects elevated Evidence female High dose Hydroxychloroquine Hypogammaglobulinemia Inflammatory biomarker inflammatory biomarkers Injury Intensive Intravenous immunoglobulin intubation IVIG IVIg. Laboratory laboratory biomarker lactate dehydrogenase Lymphocytes lymphopenia mechanical ventilation multiple organ complication neurological deficits Numerous outbreak outcome Patient patients with COVID-19 Platelets Potential treatment prognostic progressed Radiographic reflected serum severe COVID-19 severity of COVID-19 shown Spread syndrome therapy Treatment Treatment response [DOI] 10.1016/j.jfma.2021.03.014 PMC 바로가기 [Article Type] Case Reports
SARS-CoV-2 Infection and Guillain-Barré SyndromeReview Published on 2021-07-242022-10-28 Journal: Pathogens [Category] COVID-19, [키워드] acute respiratory syndrome Autoimmune disease beta-coronavirus cause caused characterized condition coronavirus COVID-19 COVID-19 illness diabetes disease Guillain-Barré syndrome Guillain–Barrè syndrome Headaches higher risk loss of taste lung medical condition Mild Neurological complication neurological deficits neurological manifestation outbreak pandemic SARS-CoV-2 SARS-COV-2 infection SARS-CoV2 infection severe complication syndrome Wuhan, China [DOI] 10.3390/pathogens10080936 PMC 바로가기 [Article Type] Review
Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infectionSARS-CoV-2 감염의 치사율에 대한 중추 신경계 감염 및 신경 침습 경로 및 신경학적 관여의 증거Review Published on 2021-03-012022-09-11 Journal: Journal of medical virology [Category] SARS, 치료기술, [키워드] absence acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Brain cause of death caused Central nervous system cerebrospinal fluid clinical symptom Clinical symptoms CNS coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus-2 COVID-19 COVID-19 patient COVID-19 patients CSF dead death early stage Evidence evidence of global health Gustatory Health higher risk Hypothesis in vitro in vivo experiment Infection infection with SARS-CoV-2 lethality mechanism Mortality nervous system neuroinvasion Neuroinvasive neurological Neurological deficit neurological deficits Neurological involvement Neurological symptom Neurological symptoms Neuron neurons Neuropathology nine olfactory outbreak pathophysiology Pathways Patient positive provided reported SARS-CoV-2 SARS-COV-2 infection Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe COVID-19 severe COVID-19 patients Support [DOI] 10.1002/jmv.26570 PMC 바로가기 [Article Type] Review